Fonte: Hematology, Transfusion and Cell Therapy. Nome do evento: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO). Unidades: ICB, FCF
Assunto: ANTINEOPLÁSICOS
ABNT
CARLOS, Jorge Antonio Elias Godoy et al. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2022.09.265. Acesso em: 01 nov. 2024. , 2022APA
Carlos, J. A. E. G., Almeida, L. C., Lima, K., Tavares, M. T., Costa-Lotufo, L. V., Parise Filho, R., & Machado Neto, J. A. (2022). Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2022.09.265NLM
Carlos JAEG, Almeida LC, Lima K, Tavares MT, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s157-s158.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.htct.2022.09.265Vancouver
Carlos JAEG, Almeida LC, Lima K, Tavares MT, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s157-s158.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.htct.2022.09.265